Connect with us

PMR

Posted 10 months ago in Member Question

Hello all,
There are guides to RA in defining RA response, remission, relapse etc. But is anyone involved in these definitions for PMR?
2012 guidelines suggest treatment aim is for "clinical improvement" as the first goal. We are instructed to abide more by patient symptoms and not CRP ESR. To me, this is what I did but it seems we can and should have better clinical and labs to help us verify our choices in a more objective fashion.
This is what I found near the end of Management or PMR ACR/EULAR 2015 published in Arthritis and Rheumatology in 2015.
"Future prospective studies aimed at
the validation of new definitions of response, remission
and relapse are, therefore, required to enable a targeted
treatment approach in PMR (66)"
So reach out if you are involved.


Comments

Interesting question, very valid.
I am a PA with 27 years of Rheumatology experience and a grandfather PA with 47 years of clinical practice. I have treated many PMR patients and find very few to be just alike. The clinical presentation often is similar, but not always. Labs often are helpful, but again, not always. I generally find that the patient holds the answer in response to treatment being started. PMR can be very elusive at times, that’s why clinical guidelines are just that, a set of principles determined by observations, yet not a black and white set of rules. Classic PMR can have a sudden onset. Go to bed fine, wake up hurting. These quickly respond to low dose steroids, 10.15 mg per day. The key in treating them is a gradual lowering of the dose from the dose amount that abated the Sx. Often the dose is 20 mg. At that point I lower the dose by 2.5 mg a day every 2-3 weeks, perhaps a month if needed. Dose lowering is always as tolerated by the patient, not a strict automatic. Once they get to 10 mg a day, I lower by 1 mg a month. Yes I monitor the markers, but my decision is based on patient perception and exam, primarily because comorbid conditions can affect the markers. I tell them they may be on some dose for up to a year. A DMARD often is started early to hasten the length of the steroid therapy. Failure to respond means either the Dx is not correct or you better look for cancer, which often masquerades as PMR. Finally, some PMR never goes away and requires doses of 1-3 mg per day to be stable. Test these waters every 3 months. It’s amazing how sensitive this condition is to small dose changes. This is what often confuses the primary care people who expect a quick fix. Finally, watch for early signs of RA, which can follow a PMR episode.
Don’t let your bias against steroids influence you too much. Yes, be cautious but follow the patient close enough to see what pattern is emerging.
All patients are unique which so tailor the approach to their response, not a set of guidelines or your fear of steroid use. Other Tx options such as biologic therapy should ofcourse be considered.
I have been fooled many times, you will be too.


Only active members can comment on this announcement.

Learn more about membership